Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus
To test the utility of gene therapeutic approaches for the treatment of pain, a recombinant herpes simplex virus, type 1, has been engineered to contain the cDNA for an opioid peptide precursor, human preproenkephalin, under control of the human cytomegalovirus promoter. This virus and a similar rec...
Spremljeno u:
| Izdano u: | Proc Natl Acad Sci U S A |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
1999
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC15921/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10077663/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.96.6.3211 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|